https://www.marketscreener.com/quote/stock/AGIOS-PHARMACEUTICALS-INC-13709228/news/Agios-Pharmaceuticals-Inc-Announces-Phase-3-Energize-Study-of-Mitapivat-Met-Primary-Endpoint-and-B-45668824/?utm_source=telegram&utm_medium=social&utm_campaign=share